The Association for Diagnostics & Laboratory Medicine is urging Congress and federal agencies to update regulations to address AI bias in clinical lab systems, citing risks to marginalized patient groups from models trained on limited data.
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
The automated, PCR-free DNA library prep solution is designed for whole genome sequencing, targeting mid-throughput clinical and translational labs.
The three-tube system designed to reduce contamination risk and improve workflow by enabling expanded urine testing from a single specimen.
ClearNote Health has launched an enhanced pancreatic cancer test, reporting 82.6% sensitivity and 97.5% specificity in high-risk patients using a multianalyte, multiomic blood-based approach.
